A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use
Clinical trial NCT03145857 · RECRUITING
Trial details
- NCT number
- NCT03145857
- Sponsor
- AHS Cancer Control Alberta
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-05
- Primary completion
- 2040-08-01
- Enrollment
- 1534
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.